Cargando…

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes

To unravel associations between plasma xanthine oxidoreductase (XOR) and diabetic vascular complications, especially distal symmetric polyneuropathy (DSP), we investigated plasma XOR activities using a novel assay. Patients with type 2 diabetes mellitus (T2DM) with available nerve conduction study (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujishiro, Midori, Ishihara, Hisamitsu, Ogawa, Katsuhiko, Murase, Takayo, Nakamura, Takashi, Watanabe, Kentaro, Sakoda, Hideyuki, Ono, Hiraku, Yamamotoya, Takeshi, Nakatsu, Yusuke, Asano, Tomoichiro, Kushiyama, Akifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391363/ https://www.ncbi.nlm.nih.gov/pubmed/34440256 http://dx.doi.org/10.3390/biomedicines9081052

Ejemplares similares

Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines
por: Kanna, Machi, et al.
Publicado: (2023)

Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity
por: Yamamotoya, Takeshi, et al.
Publicado: (2017)

Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis
por: Kushiyama, Akifumi, et al.
Publicado: (2016)

Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations
por: Nakatsu, Yusuke, et al.
Publicado: (2016)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model
por: Inoue, Masa-Ki, et al.
Publicado: (2018)

Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice
por: Mizuno, Yu, et al.
Publicado: (2019)

Involvement of neuronal and muscular Trk-fused gene (TFG) defects in the development of neurodegenerative diseases
por: Yamamotoya, Takeshi, et al.
Publicado: (2022)

Pathological Role of Pin1 in the Development of DSS-Induced Colitis
por: Matsunaga, Yasuka, et al.
Publicado: (2021)

Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins
por: Inoue, Masa-Ki, et al.
Publicado: (2019)

High-fat diet feeding significantly attenuates anagliptin-induced regeneration of islets of Langerhans in streptozotocin-induced diabetic mice
por: Shinjo, Takanori, et al.
Publicado: (2015)

Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells
por: Akasaka, Yasuyuki, et al.
Publicado: (2023)

Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages
por: Yamazaki, Hiroki, et al.
Publicado: (2018)

Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications
por: Okubo, Hirofumi, et al.
Publicado: (2018)

The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice
por: Nakatsu, Yusuke, et al.
Publicado: (2017)

Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus
por: Qiang, Shirong, et al.
Publicado: (2015)

Carnosic Acid and Carnosol Activate AMPK, Suppress Expressions of Gluconeogenic and Lipogenic Genes, and Inhibit Proliferation of HepG2 Cells
por: Hasei, Shun, et al.
Publicado: (2021)

Prolyl isomerase Pin1 binds to and stabilizes acetyl CoA carboxylase 1 protein, thereby supporting cancer cell proliferation
por: Ueda, Koji, et al.
Publicado: (2019)

Reduced SHARPIN and LUBAC Formation May Contribute to CCl(4)- or Acetaminophen-Induced Liver Cirrhosis in Mice
por: Yamamotoya, Takeshi, et al.
Publicado: (2017)

Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice
por: Inoue, Masa-Ki, et al.
Publicado: (2019)

Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines
por: Kanaoka, Ryuhei, et al.
Publicado: (2015)

Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice
por: Iwashita, Misaki, et al.
Publicado: (2013)

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
por: Matsunaga, Yasuka, et al.
Publicado: (2015)

Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus
por: Fujishiro, Midori, et al.
Publicado: (2017)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm
por: Watanabe, Ken, et al.
Publicado: (2021)

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease
por: Shimizu, Megumi, et al.
Publicado: (2023)

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care
por: Okazaki, Hirotake, et al.
Publicado: (2019)

Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women
por: Kosaki, Keisei, et al.
Publicado: (2018)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
por: Watanabe, Ken, et al.
Publicado: (2020)

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients
por: Terawaki, Hiroyuki, et al.
Publicado: (2018)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020)

Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice
por: Okubo, Hirofumi, et al.
Publicado: (2016)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases
por: Sato, Ken, et al.
Publicado: (2023)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7umqsptg10qelu2cjpgh56hqh1